Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline Pharmaceuticals Limited  

(Public, BOM:500660)   Watch this stock  
Find more results for BOM: 500660
-4.75 (-0.20%)
Real-time:   9:15AM GMT+5:30
BOM real-time data - Disclaimer
Currency in INR
Range 2,425.00 - 2,425.00
52 week 2,309.05 - 2,770.00
Open 2,425.00
Vol. 1.00
Mkt cap 206.48B
P/E 62.71
Div/yield 30.00/1.24
EPS 38.67
Shares 84.70M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '04) 2017
Net profit margin -45.32% 11.23%
Operating margin -21.28% 13.24%
EBITD margin - 13.99%
Return on average assets - 11.12%
Return on average equity - 16.08%
Employees 4,697 -
CDP Score - -


Dr Annie Besant Road, Worli
MUMBAI, 400030
+91-22-24959595 (Phone)
+91-22-24981526 (Fax)

Website links


GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The Company's product portfolio includes prescription medicines and vaccines. The Company's prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The Company's manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore.

Officers and directors

Puja Thakur Chief Financial Officer, Whole Time Director
D. Bartaria Executive Vice President– Pharmaceuticals
H. Buch Executive Vice President - Pharmaceuticals
Ajay A. Nadkarni Compliance Officer, Company Secretary, General Manager - Administration
S. Khanna Vice President - Finance
Annaswamy Vaidheesh Managing Director, Vice President, South Asia
S. Dheri Vice President - Biologicals
K. Hazari Vice President - Legal & Corporate Affairs
V. Desai General Manager - Medical & Clinical Research
Andrew Aristidou Executive Director